Monoclonal Antibody Treatment
32 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
32
Total Reports
1
Deaths Reported
310.0%
Death Rate
Active Ingredients
Monoclonal Antibody Treatment
Administration Routes
UnknownSubcutaneousParenteral
Species Affected
Dog 32
Most Affected Breeds
Beagle 3
Chihuahua 3
Boxer (German Boxer) 3
Shih Tzu 2
Shepherd Dog - German 2
Pug 2
Terrier - Yorkshire 2
Terrier - Boston 2
Retriever - Labrador 2
Pit Bull 2
Most Reported Reactions
Lack of efficacy - NOS 7
Vomiting 6
Panting 6
Abnormal movement NOS 4
Corneal ulcer 4
Diarrhoea 4
Decreased appetite 4
Lethargy (see also Central nervous system depression in Neurological) 4
Behavioural disorder NOS 3
Lethargy (see also Central nervous system depression in 'Neurological') 3
Abdominal cavity haemorrhage 3
Skin inflammation NOS 3
Outcome Breakdown
Outcome Unknown
19 (59.4%)
Recovered/Normal
10 (31.3%)
Ongoing
2 (6.3%)
Died
1 (3.1%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.